Cargando…
The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets
Cholangiocarcinoma (CCA) is a relatively rare malignancy that arises from the epithelial cells of the intrahepatic, perihilar and distal biliary tree. Intrahepatic CCA (ICC) represents the second most common primary liver cancer, after hepatocellular cancer. Two-thirds of the patients with ICC prese...
Autores principales: | Chong, Dawn Q., Zhu, Andrew X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216834/ https://www.ncbi.nlm.nih.gov/pubmed/27102149 http://dx.doi.org/10.18632/oncotarget.8775 |
Ejemplares similares
-
Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the ‘NSCLC’ of GI Oncology?
por: Gupta, Amol, et al.
Publicado: (2023) -
Emerging molecular targets and therapy for cholangiocarcinoma
por: Kayhanian, Hamzeh, et al.
Publicado: (2017) -
Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
por: Simile, Maria Maddalena, et al.
Publicado: (2019) -
Targeted Therapies for Perihilar Cholangiocarcinoma
por: Gray, Simon, et al.
Publicado: (2022) -
Targeted Therapies in Advanced Cholangiocarcinoma
por: Storandt, Michael H., et al.
Publicado: (2023)